CN110585381A - Medicinal and edible composition for expelling toxoplasma gondii and preparation method thereof - Google Patents
Medicinal and edible composition for expelling toxoplasma gondii and preparation method thereof Download PDFInfo
- Publication number
- CN110585381A CN110585381A CN201910922023.0A CN201910922023A CN110585381A CN 110585381 A CN110585381 A CN 110585381A CN 201910922023 A CN201910922023 A CN 201910922023A CN 110585381 A CN110585381 A CN 110585381A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicinal
- toxoplasma gondii
- edible composition
- selenium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 29
- 241000223997 Toxoplasma gondii Species 0.000 title claims abstract description 26
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims abstract description 27
- 229910052711 selenium Inorganic materials 0.000 claims abstract description 27
- 239000011669 selenium Substances 0.000 claims abstract description 27
- 241000045403 Astragalus propinquus Species 0.000 claims abstract description 17
- 244000268590 Euryale ferox Species 0.000 claims abstract description 17
- 235000006487 Euryale ferox Nutrition 0.000 claims abstract description 17
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 17
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 17
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims abstract description 17
- 244000097577 Rhus javanica Species 0.000 claims abstract description 17
- 235000010889 Rhus javanica Nutrition 0.000 claims abstract description 17
- 241000222481 Schizophyllum commune Species 0.000 claims abstract description 17
- 240000000147 Torreya grandis Species 0.000 claims abstract description 17
- 235000016410 Torreya grandis Nutrition 0.000 claims abstract description 17
- 235000006533 astragalus Nutrition 0.000 claims abstract description 17
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 17
- 235000011477 liquorice Nutrition 0.000 claims abstract description 17
- 210000000582 semen Anatomy 0.000 claims abstract description 17
- 239000002994 raw material Substances 0.000 claims abstract description 12
- 241000218236 Cannabis Species 0.000 claims description 16
- 239000000706 filtrate Substances 0.000 claims description 15
- 239000000341 volatile oil Substances 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 244000269722 Thea sinensis Species 0.000 claims description 10
- 238000001914 filtration Methods 0.000 claims description 10
- 239000012530 fluid Substances 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 3
- 230000001846 repelling effect Effects 0.000 claims 6
- 230000000694 effects Effects 0.000 abstract description 5
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 201000005485 Toxoplasmosis Diseases 0.000 abstract description 3
- 230000002195 synergetic effect Effects 0.000 abstract description 2
- 240000004308 marijuana Species 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 description 8
- 241000223996 Toxoplasma Species 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 244000000056 intracellular parasite Species 0.000 description 2
- ACTOXUHEUCPTEW-BWHGAVFKSA-N 2-[(4r,5s,6s,7r,9r,10r,11e,13e,16r)-6-[(2s,3r,4r,5s,6r)-5-[(2s,4r,5s,6s)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-10-[(2s,5s,6r)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-4-hydroxy-5-methoxy-9,16-dimethyl-2-o Chemical compound O([C@H]1/C=C/C=C/C[C@@H](C)OC(=O)C[C@@H](O)[C@@H]([C@H]([C@@H](CC=O)C[C@H]1C)O[C@H]1[C@@H]([C@H]([C@H](O[C@@H]2O[C@@H](C)[C@H](O)[C@](C)(O)C2)[C@@H](C)O1)N(C)C)O)OC)[C@@H]1CC[C@H](N(C)C)[C@@H](C)O1 ACTOXUHEUCPTEW-BWHGAVFKSA-N 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 239000004187 Spiramycin Substances 0.000 description 1
- 206010057179 Toxoplasma infections Diseases 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- MQTOSJVFKKJCRP-BICOPXKESA-N azithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)N(C)C[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 MQTOSJVFKKJCRP-BICOPXKESA-N 0.000 description 1
- 229960004099 azithromycin Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 1
- 229960002227 clindamycin Drugs 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000004220 fundus oculi Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- WKSAUQYGYAYLPV-UHFFFAOYSA-N pyrimethamine Chemical compound CCC1=NC(N)=NC(N)=C1C1=CC=C(Cl)C=C1 WKSAUQYGYAYLPV-UHFFFAOYSA-N 0.000 description 1
- 229960000611 pyrimethamine Drugs 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 229960001294 spiramycin Drugs 0.000 description 1
- 229930191512 spiramycin Natural products 0.000 description 1
- 235000019372 spiramycin Nutrition 0.000 description 1
- SEEPANYCNGTZFQ-UHFFFAOYSA-N sulfadiazine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=NC=CC=N1 SEEPANYCNGTZFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004306 sulfadiazine Drugs 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8998—Hordeum (barley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/904—Stemonaceae (Stemona family), e.g. croomia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to the technical field of medicinal and edible compositions, in particular to a medicinal and edible composition for expelling toxoplasma gondii and a preparation method thereof. The medicinal and edible composition for expelling toxoplasma gondii mainly comprises the following raw materials in parts by weight: 2-5 parts of selenium malt, 10-15 parts of brucea javanica, 10-20 parts of astragalus membranaceus, 5-18 parts of radix stemonae, 6-10 parts of liquorice, 3-8 parts of Chinese torreya, 2-8 parts of fructus cannabis, 1-3 parts of semen euryales and 0.5-1.5 parts of schizophyllum commune. The medicinal and edible composition for expelling toxoplasma gondii and the preparation method thereof have reasonable compatibility and synergistic effect among the components, solve the toxoplasma gondii infection in most human bodies through the medicinal and edible composition, have no toxic or side effect, and are suitable for use in life.
Description
Technical Field
The invention relates to the technical field of medicinal and edible compositions, in particular to a medicinal and edible composition for expelling toxoplasma gondii and a preparation method thereof.
Background
Toxoplasma Gondii (Toxoplasma Gondii), also called a three-corpse worm, is an intracellular parasite. Parasitizing in cells, flowing with blood, reaching all parts of the body, damaging the brain, heart and fundus oculi, causing the immunity of people to be reduced and various diseases to be suffered. It is an obligate intracellular parasite of the order coccidioideae, isosporozoa, genus toxoplasma.
At present, a plurality of hospitals in China already carry out the detection of toxoplasma gondii antibodies. However, the quality of the examination is not high, the quality of the reagent and the screening method need to be standardized, and many clinicians are not familiar with the significance and the correct judgment of the result of the serological examination. False positive results and wrong interpretation by doctors caused by low inspection quality not only waste money and wealth of the sick families, but also cause unnecessary anxiety of the sick and the family members and bring great mental burden. The traditional toxoplasma resisting medicines are sulfadiazine and pyrimethamine, and the medicines such as spiramycin, clindamycin, azithromycin and the like can be adopted for treatment at present, but the medicines have certain toxic and side effects, are required to be treated according to the advice, are not suitable in life, and cannot solve toxoplasma infection in most human bodies.
Disclosure of Invention
The invention aims to provide a medicinal and edible composition for expelling toxoplasma gondii and a preparation method thereof, overcomes the defects of the prior art, solves toxoplasma gondii infection in most human bodies through the medicinal and edible composition, has no toxic or side effect, and is suitable for use in life.
The technical scheme adopted by the invention for solving the technical problems is as follows:
a medicinal and edible composition for expelling Toxoplasma gondii comprises: the material mainly comprises the following raw materials in parts by weight: 2-5 parts of selenium malt, 10-15 parts of brucea javanica, 10-20 parts of astragalus membranaceus, 5-18 parts of radix stemonae, 6-10 parts of liquorice, 3-8 parts of Chinese torreya, 2-8 parts of fructus cannabis, 1-3 parts of semen euryales and 0.5-1.5 parts of schizophyllum commune.
Preferably, the material mainly comprises the following raw materials in parts by weight: 4 parts of selenium malt, 13 parts of brucea javanica, 16 parts of astragalus mongholicus, 10 parts of radix stemonae, 8 parts of liquorice, 5 parts of Chinese torreya, 7 parts of fructus cannabis, 2 parts of semen euryales and 1 part of schizophyllum commune.
Preferably, the material mainly comprises the following raw materials in parts by weight: 2 parts of selenium malt, 10 parts of brucea javanica, 10 parts of astragalus membranaceus, 5 parts of radix stemonae, 6 parts of liquorice, 3 parts of Chinese torreya, 2 parts of fructus cannabis, 1 part of semen euryales and 0.5 part of schizophyllum commune.
Preferably, the material mainly comprises the following raw materials in parts by weight: 5 parts of selenium malt, 15 parts of brucea javanica, 20 parts of astragalus membranaceus, 18 parts of radix stemonae, 10 parts of liquorice, 8 parts of Chinese torreya, 8 parts of fructus cannabis, 3 parts of semen euryales and 1.5 parts of schizophyllum commune.
A preparation method of a medicinal and edible composition for expelling toxoplasma gondii comprises the following steps:
(1) distilling brucea javanica, astragalus membranaceus, radix stemonae and liquorice in specified weight parts for 1-2 times by using steam, wherein each time lasts for 2-10 hours, collecting volatile oil and distilled residual liquid, decocting the decoction dregs for 1-3 times to obtain an extracting solution, filtering, collecting filtrate, mixing the filtrate with the distilled residual liquid, and concentrating to obtain a clear paste A, wherein the relative density of the clear paste A at 55-60 ℃ is 1.35-1.44;
(2) decocting the residue after extracting volatile oil in step (1), Chinese torreya, fructus cannabis, semen euryales and schizophyllum commune with water for 1-3 times, each time for 1-3h, filtering, collecting filtrate, and concentrating to obtain fluid extract B, wherein the relative density of the fluid extract B at 55-60 ℃ is 1.35-1.44;
(3) mixing the clear paste A obtained in the step (1) with the clear paste B obtained in the step (2) to obtain an extract, and adding the malt selenium in a specified weight part into the extract;
(4) and (3) uniformly mixing the extract added with the selenium malted tea in the step (3) with the volatile oil in the step (1) to obtain the selenium malted tea.
Preferably, the ratio of g: and the mass volume ratio of the decoction dregs to the water is 1:6-8 by mL.
Preferably, in step (2) of step (2), the ratio of g: and the mass volume ratio of the decoction dregs to the water is 1: 6-8.
The invention has the beneficial effects that: compared with the prior art, the medicinal and edible composition for expelling toxoplasma gondii and the preparation method thereof have the advantages that the compatibility is reasonable, the components have synergistic effect, the toxoplasma gondii infection in most human bodies is solved through the medicinal and edible composition, no toxic or side effect is caused, and the medicinal and edible composition is suitable for use in life.
Detailed Description
Example 1
A medicinal and edible composition for expelling toxoplasma gondii mainly comprises the following raw materials in parts by weight: 4 parts of selenium malt, 13 parts of brucea javanica, 16 parts of astragalus mongholicus, 10 parts of radix stemonae, 8 parts of liquorice, 5 parts of Chinese torreya, 7 parts of fructus cannabis, 2 parts of semen euryales and 1 part of schizophyllum commune.
A preparation method of a medicinal and edible composition for expelling toxoplasma gondii comprises the following steps:
(1) distilling brucea javanica, astragalus membranaceus, radix stemonae and liquorice in specified weight parts for 2 times by using water vapor, collecting volatile oil and distilled residual liquid, decocting the residues for 2 times to obtain extracting solution, filtering, collecting filtrate, mixing the filtrate with the distilled residual liquid, and concentrating to obtain clear paste A, wherein the relative density of the clear paste A at 58 ℃ is 1.4;
(2) decocting the residue after extracting volatile oil in step (1), Chinese torreya, fructus cannabis, semen euryales and schizophyllum commune with water for 2 times, each time for 2h, filtering, collecting filtrate, and concentrating to obtain fluid extract B, wherein the relative density of the fluid extract B at 58 ℃ is 1.4;
(3) mixing the clear paste A obtained in the step (1) with the clear paste B obtained in the step (2) to obtain an extract, and adding the malt selenium in a specified weight part into the extract;
(4) and (3) uniformly mixing the extract added with the selenium malted tea in the step (3) with the volatile oil in the step (1) to obtain the selenium malted tea.
Example 2
A medicinal and edible composition for expelling toxoplasma gondii is characterized in that: the material mainly comprises the following raw materials in parts by weight: 2 parts of selenium malt, 10 parts of brucea javanica, 10 parts of astragalus membranaceus, 5 parts of radix stemonae, 6 parts of liquorice, 3 parts of Chinese torreya, 2 parts of fructus cannabis, 1 part of semen euryales and 0.5 part of schizophyllum commune.
A preparation method of a medicinal and edible composition for expelling toxoplasma gondii comprises the following steps:
(1) distilling brucea javanica, astragalus membranaceus, radix stemonae and liquorice in specified weight parts for 1 time by using steam, collecting volatile oil and distilled residual liquid for 2 hours each time, decocting the dregs of a decoction for 1 time to obtain extracting solution, filtering, collecting filtrate, mixing the filtrate with the distilled residual liquid, and concentrating to obtain clear paste A, wherein the relative density of the clear paste A at 55 ℃ is 1.35;
(2) decocting the residue after extracting volatile oil in step (1), Chinese torreya, fructus cannabis, semen euryales and schizophyllum commune with water for 1 time, each time for 1h, filtering, collecting filtrate, and concentrating to obtain fluid extract B, wherein the relative density of the fluid extract B at 55 ℃ is 1.35;
(3) mixing the clear paste A obtained in the step (1) with the clear paste B obtained in the step (2) to obtain an extract, and adding the malt selenium in a specified weight part into the extract;
(4) and (3) uniformly mixing the extract added with the selenium malted tea in the step (3) with the volatile oil in the step (1) to obtain the selenium malted tea.
Example 3
A medicinal and edible composition for expelling toxoplasma gondii mainly comprises the following raw materials in parts by weight: 5 parts of selenium malt, 15 parts of brucea javanica, 20 parts of astragalus membranaceus, 18 parts of radix stemonae, 10 parts of liquorice, 8 parts of Chinese torreya, 8 parts of fructus cannabis, 3 parts of semen euryales and 1.5 parts of schizophyllum commune.
A preparation method of a medicinal and edible composition for expelling toxoplasma gondii comprises the following steps:
(1) distilling brucea javanica, astragalus membranaceus, radix stemonae and liquorice in specified weight parts for 2 times by using water vapor, 10 hours each time, collecting volatile oil and distilled residual liquid, decocting the dregs of a decoction for 3 times to obtain an extracting solution, filtering, collecting filtrate, mixing the filtrate with the distilled residual liquid, and concentrating to obtain a clear paste A, wherein the relative density of the clear paste A at 60 ℃ is 1.44;
(2) decocting the residue after extracting volatile oil in step (1), Chinese torreya, fructus cannabis, semen euryales and schizophyllum commune with water for 3 times, each time for 3h, filtering, collecting filtrate, and concentrating to obtain fluid extract B, wherein the relative density of the fluid extract B at 60 ℃ is 1.44;
(3) mixing the clear paste A obtained in the step (1) with the clear paste B obtained in the step (2) to obtain an extract, and adding the malt selenium in a specified weight part into the extract;
(4) and (3) uniformly mixing the extract added with the selenium malted tea in the step (3) with the volatile oil in the step (1) to obtain the selenium malted tea.
Experimental example 1
The clinical practice test of 300 patients with toxoplasma in vivo is selected, one group is formed for every 100 patients, one dose is taken for each group, and 15 days are a course of treatment.
The therapeutic criteria are as follows:
and (3) healing: the symptoms and physical signs return to normal;
the effect is shown: the symptoms and physical symptoms are obviously improved;
the method has the following advantages: the symptoms and the physical symptoms are improved;
and (4) invalidation: the symptoms and physical symptoms are not obviously improved, and the symptoms are as before.
The total effective rate is the cure rate + significant efficiency + effective rate.
The results of the experiment are shown in table 1:
TABLE 1
The above embodiments are only specific examples of the present invention, and the protection scope of the present invention includes but is not limited to the product forms and styles of the above embodiments, and any suitable changes or modifications made by those skilled in the art according to the claims of the present invention shall fall within the protection scope of the present invention.
Claims (7)
1. A medicinal and edible composition for expelling toxoplasma gondii is characterized in that: the material mainly comprises the following raw materials in parts by weight: 2-5 parts of selenium malt, 10-15 parts of brucea javanica, 10-20 parts of astragalus membranaceus, 5-18 parts of radix stemonae, 6-10 parts of liquorice, 3-8 parts of Chinese torreya, 2-8 parts of fructus cannabis, 1-3 parts of semen euryales and 0.5-1.5 parts of schizophyllum commune.
2. The medicinal and edible composition for repelling toxoplasma gondii as claimed in claim 1, wherein: the material mainly comprises the following raw materials in parts by weight: 4 parts of selenium malt, 13 parts of brucea javanica, 16 parts of astragalus mongholicus, 10 parts of radix stemonae, 8 parts of liquorice, 5 parts of Chinese torreya, 7 parts of fructus cannabis, 2 parts of semen euryales and 1 part of schizophyllum commune.
3. The medicinal and edible composition for repelling toxoplasma gondii as claimed in claim 1, wherein: the material mainly comprises the following raw materials in parts by weight: 2 parts of selenium malt, 10 parts of brucea javanica, 10 parts of astragalus membranaceus, 5 parts of radix stemonae, 6 parts of liquorice, 3 parts of Chinese torreya, 2 parts of fructus cannabis, 1 part of semen euryales and 0.5 part of schizophyllum commune.
4. The medicinal and edible composition for repelling toxoplasma gondii as claimed in claim 1, wherein: the material mainly comprises the following raw materials in parts by weight: 5 parts of selenium malt, 15 parts of brucea javanica, 20 parts of astragalus membranaceus, 18 parts of radix stemonae, 10 parts of liquorice, 8 parts of Chinese torreya, 8 parts of fructus cannabis, 3 parts of semen euryales and 1.5 parts of schizophyllum commune.
5. The preparation method of the medicinal and edible composition for repelling toxoplasma gondii as claimed in claim 1, is characterized in that:
the method comprises the following steps:
(1) distilling brucea javanica, astragalus membranaceus, radix stemonae and liquorice in specified weight parts for 1-2 times by using steam, wherein each time lasts for 2-10 hours, collecting volatile oil and distilled residual liquid, decocting the decoction dregs for 1-3 times to obtain an extracting solution, filtering, collecting filtrate, mixing the filtrate with the distilled residual liquid, and concentrating to obtain a clear paste A, wherein the relative density of the clear paste A at 55-60 ℃ is 1.35-1.44;
(2) decocting the residue after extracting volatile oil in step (1), Chinese torreya, fructus cannabis, semen euryales and schizophyllum commune with water for 1-3 times, each time for 1-3h, filtering, collecting filtrate, and concentrating to obtain fluid extract B, wherein the relative density of the fluid extract B at 55-60 ℃ is 1.35-1.44;
(3) mixing the clear paste A obtained in the step (1) with the clear paste B obtained in the step (2) to obtain an extract, and adding the malt selenium in a specified weight part into the extract;
(4) and (3) uniformly mixing the extract added with the selenium malted tea in the step (3) with the volatile oil in the step (1) to obtain the selenium malted tea.
6. The preparation method of the medicinal and edible composition for repelling toxoplasma gondii as claimed in claim 5, wherein: in the step (1), the ratio of g: and the mass volume ratio of the decoction dregs to the water is 1:6-8 by mL.
7. The preparation method of the medicinal and edible composition for repelling toxoplasma gondii as claimed in claim 5, wherein: in the step (2), the ratio of g: and the mass volume ratio of the decoction dregs to the water is 1: 6-8.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910922023.0A CN110585381A (en) | 2019-09-27 | 2019-09-27 | Medicinal and edible composition for expelling toxoplasma gondii and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910922023.0A CN110585381A (en) | 2019-09-27 | 2019-09-27 | Medicinal and edible composition for expelling toxoplasma gondii and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110585381A true CN110585381A (en) | 2019-12-20 |
Family
ID=68863937
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910922023.0A Pending CN110585381A (en) | 2019-09-27 | 2019-09-27 | Medicinal and edible composition for expelling toxoplasma gondii and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110585381A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111135253A (en) * | 2020-01-16 | 2020-05-12 | 珠海汉唐生物科技工程有限公司 | Formula for eliminating toxoplasma gondii parasitism and preparation method of capsules thereof |
| CN116688022A (en) * | 2023-04-28 | 2023-09-05 | 河北锦坤动物药业有限公司 | Traditional Chinese medicine composition for treating toxoplasmosis and preparation method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1249948A (en) * | 1999-09-15 | 2000-04-12 | 李永光 | Changqing medicine powder resisting toxoplasmosis |
| CN102488743A (en) * | 2011-12-16 | 2012-06-13 | 苏州大学附属第一医院 | Chinese traditional medicine composition, preparation method thereof and Chinese traditional medicine preparation |
| CN103083500A (en) * | 2011-11-03 | 2013-05-08 | 青岛康地恩药业股份有限公司 | Chinese medicinal composition treating toxoplasmosis |
-
2019
- 2019-09-27 CN CN201910922023.0A patent/CN110585381A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1249948A (en) * | 1999-09-15 | 2000-04-12 | 李永光 | Changqing medicine powder resisting toxoplasmosis |
| CN103083500A (en) * | 2011-11-03 | 2013-05-08 | 青岛康地恩药业股份有限公司 | Chinese medicinal composition treating toxoplasmosis |
| CN102488743A (en) * | 2011-12-16 | 2012-06-13 | 苏州大学附属第一医院 | Chinese traditional medicine composition, preparation method thereof and Chinese traditional medicine preparation |
Non-Patent Citations (4)
| Title |
|---|
| 岳彩凤: "科学补硒,麦芽硒先行 ", 《经济》 * |
| 程雪娇: "15种中药抗弓形虫效果的比较研究", 《中国优秀硕士学位论文全文数据库》 * |
| 荆振宇等: "五种中草药对弓形虫体外增殖的抑制效果", 《中国兽医科学》 * |
| 赵琪等: "裂褶菌研究进展", 《食用菌学报》 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111135253A (en) * | 2020-01-16 | 2020-05-12 | 珠海汉唐生物科技工程有限公司 | Formula for eliminating toxoplasma gondii parasitism and preparation method of capsules thereof |
| CN116688022A (en) * | 2023-04-28 | 2023-09-05 | 河北锦坤动物药业有限公司 | Traditional Chinese medicine composition for treating toxoplasmosis and preparation method thereof |
| CN116688022B (en) * | 2023-04-28 | 2024-06-04 | 河北锦坤动物药业有限公司 | Traditional Chinese medicine composition for treating toxoplasmosis and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101164586B (en) | Medicinal composition for treating sexual impotence and preparation process thereof | |
| CN101310751B (en) | Detection method of medicine composition for replenishing qi and blood | |
| CN101658597B (en) | Health care step-down tea and preparation method thereof | |
| CN110585381A (en) | Medicinal and edible composition for expelling toxoplasma gondii and preparation method thereof | |
| CN101982193B (en) | Traditional Chinese medicine composition for treating pulmonary tuberculosis, preparation method and application thereof | |
| CN102266415B (en) | Application of compound traditional Chinese medicine in prevention and treatment of osteoporosis disease | |
| CN108014123A (en) | Ozonize Chinese herbal medicine, Chinese medicine preparation extract | |
| CN102058666B (en) | Chinese medicinal preparation for treating acute upper respiratory tract infection and preparation method thereof | |
| CN100473409C (en) | Medicine for treating glomerular hematuria | |
| CN103977390B (en) | A kind of preparation method and its usage of ginger onion medicated wine composition | |
| CN101062326A (en) | Chinese traditional combination having anti-fatigue function | |
| CN105395644A (en) | Traditional Chinese medicinal composition for preventing and treating coccidiosis in chicken as well as preparation method and application of traditional Chinese medicinal composition | |
| CN104306662A (en) | Traditional Chinese medicine composition for treating neurasthenia and preparation method thereof | |
| CN101411493B (en) | Cold tea for preventing and treating fatigue type sub-health and preparation method thereof | |
| CN110302307B (en) | Yin-nourishing and beauty-maintaining medicinal liquor for women and preparation method thereof | |
| CN103463244A (en) | Method for extracting blood sugar lowering substance from China roses and application of blood sugar lowering substance | |
| CN1663606A (en) | Medicine for treating radiation diseases | |
| CN105560308A (en) | Application of Flower of Hibiscus manihot L. in preparation of products for preventing and treating prostate diseases | |
| CN1330332C (en) | Medicine for curing vaginits and dermatosis and its preparation method | |
| CN101785815A (en) | Health care product with auxiliary functions on blood fat reduction and chemical liver injury protection | |
| CN105168306A (en) | Pharmaceutical composition for promoting traumatic fracture coalescence | |
| CN101766743A (en) | Drug combination for treating permenstrual syndrome | |
| CN104498297B (en) | A kind of spider health care wine and preparation method thereof | |
| CN100443093C (en) | AIDS treating medicine | |
| CN106491706A (en) | Ginkgo leaf capsule of red sage root |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20191220 |